Evidence map›Paper›PMID 29256173›Full record

ArticleStem cell reviews and reports2018

Gene Network Analysis of Interstitial Macrophages After Treatment with Induced Pluripotent Stem Cells Secretome (iPSC-cm) in the Bleomycin Injured Rat Lung.

Luca Tamò, Cedric Simillion, Youssef Hibaoui, Anis Feki, Mathias Gugger, Antje Prasse, Benedikt Jäger, Torsten Goldmann, Thomas Geiser, Amiq Gazdhar

Open access · hybridAbstract read
In one paragraph

Article in Stem cell reviews and reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Induced pluripotent stem cell-based therapies for organ fibrosis.Frontiers in bioengineering and biotechnology · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Basal-Like Cell-Conditioned Medium Exerts Anti-Fibrotic EffectsFrontiers in bioengineering and biotechnology · 2022
    Article
  9. Article
  10. Article
  11. Tenascin-C: Friend or Foe in Lung Aging?Frontiers in physiology · 2021
    Article
  12. Article
  13. Cell-Based Therapeutic Approaches for Cystic Fibrosis.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Luca TamòDepartment of Pulmonary Medicine, University Hospital Bern, 3010, Bern, Switzerland.
Cedric SimillionInterfaculty Bioinformatics Unit, University of Bern, Bern, Switzerland.
Youssef HibaouiDepartment of Gynecology and Obstetrics, University Hospital Geneva, Bern, Switzerland.
Anis FekiDepartment of Gynecology and Obstetrics, Cantonal Hospital Fribourg, Fribourg, Switzerland.
Mathias GuggerPromed Laboratories Fribourg, Fribourg, Switzerland.
Antje PrasseHannover Medical School, Clinic for Pneumology, Hanover, Germany.
Benedikt JägerFraunhofer Institute for Toxicology and Experimental Medicine, Hanover, Germany.
Torsten GoldmannPathology of the University Hospital of Lübeck and the Leibniz Research Center Borstel, Borstel, Germany.
Thomas GeiserDepartment of Pulmonary Medicine, University Hospital Bern, 3010, Bern, Switzerland.
Amiq GazdharDepartment of Pulmonary Medicine, University Hospital Bern, 3010, Bern, Switzerland. amiq.gazdhar@dbmr.unibe.ch.
University of Bern · CHFribourg Development Agency · CHFraunhofer Institute for Toxicology and Experimental Medicine · DEGerman Center for Lung Research · DEMedizinische Hochschule Hannover · DEUniversity Hospital of Bern · CHUniversity Hospital of Geneva · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 16-858
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a complex disease involving various cell types. Macrophages are essential in maintenance of physiological homeostasis, wound repair and fibrosis in the lung. Macrophages play a crucial role in repair and remodeling by altering their phenotype and secretory pattern in response to injury. The secretome of induced pluripotent stem cells (iPSC-cm) attenuates injury and fibrosis in bleomycin injured rat lungs. In the current study, we evaluate the effect of iPSC-cm on gene expression and phenotype of interstitial macrophage in bleomycin injured rat lungs in vivo. iPSC-cm was intratracheally instilled 7 days after bleomycin induced lung injury and assessed 7 days later and single cell isolation was performed. Macrophages were FACS sorted and microarray analysis was performed. We characterized changes in the rat lung interstitial macrophages using transcriptional profiling. iPSC-cm reduced the total collagen content of the lung and reduced different macrophage populations. Gene set enrichment analysis revealed involvement of three essential pathways (a) immune modulation, (b) branching morphogenesis and (c) canonical Wnt signaling. This study demonstrates that iPSC-cm reduces fibrosis in bleomycin injured rat lung by partially altering the macrophages and regulating their gene expression.

Indexed as

AnimalsBleomycinCells, CulturedFlow CytometryGene Regulatory NetworksHumansInduced Pluripotent Stem CellsLungMacrophagesMaleRatsStem CellsBleomycinInduced pluripotent stem cellsLung fibrosisMacrophagesStem cell secretome

Identifiers

PMID29256173
PMCPMC5960485
OpenAlexW2780828639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.